Blanver

Blanver develops, manufactures, and commercializes high-quality pharmaceuticals and active pharmaceutical ingredients. The company specializes in antiretroviral therapies for HIV/AIDS, antivirals for hepatitis B/C, osteoporosis treatments, and psychiatric medications such as lithium carbonate. It supplies both finished dosage forms and APIs to the Brazilian Ministry of Health as well as international partners. Its portfolio includes commercialized products like Tenofovir Disoproxil Fumarate tablets/API (HIV/Hepatitis B), Sofosbuvir tablets/API (Hepatitis C), fixed-dose combinations for HIV treatment adherence improvement, osteoporosis drugs, and lithium carbonate API.